English Español

Home
Tests
Products
Companies
Technologies
Topics
Insights
Buyer's Guide
Partners

Home
Tests
Products
Companies
Technologies
Topics
Insights
Buyer's Guide
Partners

English Español

Loading

Loading

IVDmap

Global entry platform for product discovery, supplier mapping, and procurement decision support.

Platform

Home
Products
Companies
Technologies
Insights
Tools
Glossary

Buyers

Buyer's Guide
Resource Packs
Request Quote
Case Studies

Partners

Become a Partner
OEM Cooperation
Partner application

Company / Legal

Contact
Privacy
Terms
Disclaimer
[email protected]

Regulatory Notice Disclaimer Privacy TermsFor professional use only. Availability varies by country.

Search IVDmap

Search products, companies, tests, and guides — go from query to quote request in one place.

Search

Showing 1 - 12 of 21 for “Breast Cancer Type 1 Susceptibility Protein Measurement”

All Results (21)Article (21)

Article

A two-dimensional nanosheet-enhanced fluorescent biosensor with nucleic acid amplification for breast cancer-related miRNA detection.

Research record from Talanta, 2026-03-27. PMID 41905041.

Article

Bioinformatics-based identification of capsaicin target genes associated with trastuzumab resistance in HER2-positive breast cancer: in silico and qRT-PCR validation studies.

Research record from In Silico Pharmacol, 2026-10-01. PMID 42827612.

Article

Clinical Validation of Digital PCR-Based ctDNA Detection for Risk Stratification in Residual Triple-Negative Breast Cancer: TRICIA Trial Results.

Research record from Clin Cancer Res, 2026-04-01. PMID 41662447.

Article

Comparison of the somatic mutations in breast carcinomas in sporadic and BRCA1 carrier patients through targeted next generation sequencing.

Research record from Hum Pathol, 2026-04-27. PMID 42055234.

Article

Development and validation of a quantitative pcr array assay for the detection of viral sequences in breast cancer.

Research record from J Genet Eng Biotechnol, 2026-04-16. PMID 42309598.

Article

Development of a LiDia-SEQ™ platform compatible breast cancer panel and testing with metastatic breast cancer patient samples: A rapid, sample-to-result, fully integrated next-generation sequencing (NGS)-based platform, LiDia-SEQ, for use at the point-of-need.

Research record from J Liq Biopsy, 2026-06-02. PMID 42325535.

Article

Development of new liquid chromatography-tandem mass spectrometry methods for the quantification of seven metabolites in three related breast cancer cell lines.

Research record from J Pharm Biomed Anal, 2026-06-13. PMID 42320281.

Article

Discovery of novel circular RNAs of the apoptosis-related BAX gene in breast cancer, by combining nanopore and next-generation sequencing.

Research record from Mol Genet Genomics, 2026-03-17. PMID 41843205.

Article

Evaluating Cell-Free DNA Quantification and Integrity in Breast Cancer Using Fluorometric, Electrophoretic and PCR-Based Platforms.

Research record from Methods Protoc, 2026-08-24. PMID 42776677.

Article

Evaluation of HER2 status and characteristics by next-generation sequencing in breast cancer.

Research record from Front Mol Biosci, 2026-06-23. PMID 42416488.

Article

Identification of NETs and inflammation-related prognostic genes in breast cancer and PCR experimental validation.

Research record from Front Genet, 2026-08-21. PMID 42695096.

Article

Identification of Somatic and Germline Mutations Influencing Treatment Outcomes and Disease Susceptibility in Tunisian Triple-Negative Breast Cancer Using Next-Generation Sequencing.

Research record from Br J Biomed Sci, 2026-04-22. PMID 42099507.

Previous 1 2 Next